Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy

Published:2019-07-01 Issue:7 Volume:4 Page:644
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Maron Martin S.¹,Rowin Ethan J.¹,Wessler Benjamin S.²,Mooney Paula J.¹,Fatima Amber¹,Patel Parth¹,Koethe Benjamin C.²,Romashko Mikhail¹,Link Mark S.³⁴,Maron Barry J.¹

Affiliation:

1. Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts

2. Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts

3. Division of Cardiology, Department of Internal Medicine, University of Texas, Dallas

4. Southwestern Medical Center, Dallas, Texas

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

http:///jamacardiology/article-pdf/4/7/644/17729255/jamacardiology_maron_2019_oi_190022.pdf

Reference58 articles.

1. Clinical course and management of hypertrophic cardiomyopathy.;Maron;N Engl J Med,2018

2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).;Elliott;Eur Heart J,2014

3. How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice.;Maron;JAMA Cardiol,2016